Certification of Creatinine in a Human Serum Reference Material by GC-MS and LC-MS

  • Nathan G Dodder
    Analytical Chemistry Division and Statistical Engineering Division,
  • Susan S-C Tai
    Analytical Chemistry Division and Statistical Engineering Division,
  • Lorna T Sniegoski
    Analytical Chemistry Division and Statistical Engineering Division,
  • Nien F Zhang
    National Institute of Standards and Technology, Gaithersburg, MD
  • Michael J Welch
    Analytical Chemistry Division and Statistical Engineering Division,

説明

<jats:title>Abstract</jats:title> <jats:p>Background: To meet recommendations given by the Laboratory Working Group of the National Kidney Disease Education Program for improving serum creatinine measurements, NIST developed standard reference material (SRM) 967 Creatinine in Frozen Human Serum. SRM 967 is intended for use by laboratories and in vitro diagnostic equipment manufacturers for the calibration and evaluation of routine clinical methods.</jats:p> <jats:p>Methods: The SRM was produced from 2 serum pools with different creatinine concentrations. The concentrations were certified using a higher-order isotope-dilution GC-MS method and an isotope-dilution LC-MS method. The LC-MS method is a potential higher-order reference measurement procedure.</jats:p> <jats:p>Results: The GC-MS mean (CV) concentrations were 67.0 (0.9%) μmol/L for serum pool 1 and 346.1 (0.45%) μmol/L for serum pool 2. The LC-MS results were 66.1 (0.2%) μmol/L and 346.3 (0.2%) μmol/L, respectively. For serum pool 1, there was a 1.4% difference between the mean GC-MS and LC-MS measurements, and a 0.10% difference for serum pool 2. The results from the 2 methods were combined to give the certified concentrations and expanded uncertainties.</jats:p> <jats:p>Conclusions: The certified concentration (expanded uncertainty) of SRM 967 was 66.5 (1.8) μmol/L for serum pool 1 (a value close to the diagnostically important concentration of 88.4 μmol/L) and 346.2 (7.4) μmol/L for serum pool 2 (a concentration corresponding to that expected in a patient with chronic kidney disease).</jats:p>

収録刊行物

  • Clinical Chemistry

    Clinical Chemistry 53 (9), 1694-1699, 2007-09-01

    Oxford University Press (OUP)

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ